Clinical Trial Update: Retinol Binding Protein 4 Protein in Alopecia Areata Treated With Barcitinib [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating Barcitinib for alopecia areata; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Barcitinib (baricitinib)

Snippet

Sponsor: South Valley University | Conditions: Alopecia Areata | Phase 1 | Status: ACTIVE_NOT_RECRUITING